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Hepatic encephalopathy has been defined as a spectrum of neuropsychiatric 
abnormalities seen in patients with liver dysfunction after exclusion of an intrinsic 
brain disease [1]. Minimal hepatic encephalopathy (MHE) has been used to describe 
a subset of patients with the mildest form of encephalopathy, not detected on clinical 
examination, but detected on psychometric testing [1, 2]. The term applies to both 
patients with cirrhosis and patients with portosystemic shunts without intrinsic liver 
disease   like isolated   portal vein thrombosis [1]. The assessment of children with 
chronic liver disease (CLD) for encephalopathy is very challenging, particularly when 
assessing a frightened, unwell, younger child making it even more difficult to 
diagnose MHE. 
 There are a few studies to suggest that children with CLD are at risk of developing a 
cognitive impairment, which is worse when the disease manifests in the first year of 
life [3, 4]. These children have been shown to perform worse on measures of verbal, 
non-verbal and overall intelligence. In addition, liver transplantation does not correct 
these deficiencies and children post liver transplantation have been shown to have 
lower overall language skills, a decrease in non-verbal intelligence and lower 
academic achievements [5, 6]. The precise mechanism for these deficiencies is not 
known. Nutritional deficiencies are a possible factor, but the presence of MHE and 
the effect of toxic metabolites on the developing brain could be another. The ability to 
identify and treat factors that may be affecting the cognitive development of these 
young patients could have an exponential benefit for these children’s long term 
academic and overall life achievements. We therefore welcome in this edition of 
Journal of Hepatology the paper by Srivastava et al [7] which endeavours to tackle 
this very interesting issue of MHE in children with CLD, providing us with some 
insight into the mechanism of its development as well as indices on imaging that can 
help diagnose it. 
The prevalence of MHE as reported in this study seems to be similar in children and 
adults at about 50% [8-10]. The ammonia hypothesis suggests that raised ammonia 
levels lead to an increase of glutamine in brain astrocytes causing them to swell with 
subsequent neuro-dysfunction with additional contributory factors being endogenous 
benzodiazepines and the presence of inflammation [11, 12]. MHE in adults with 
cirrhosis has been associated with a reduced 5 year survival rate [13] and has been 
associated with reduced quality of life [14].There is no similar data available in 
children but some  neurological abnormalities described with MHE may persist even 
after liver transplantation [15] making it crucial to detect MHE and offer intervention. 
Various modalities have been used to diagnose MHE including EEG, critical flicker 
frequency, continuous reaction time, inhibitory control test, computerised test 
  
batteries, arterial spin labelling MRI with the psychometric hepatic encephalopathy 
score (PHES) considered to be the gold standard [16, 17].  
Srivastava et al [7] studied prospectively 67 children with CLD and compare them to 
37 healthy children. The study evaluates a plethora of parameters that could 
potentially be associated with MHE, including blood ammonia, IL6 and TNFα levels 
as well as calculating PELD and MELD scores and classifying their patients 
according to Child class. The children undergo NPT, magnetic resonance 
spectroscopy (HMRS) to study brain metabolite changes (specifically glutamine, 
choline and myoinositol) and also have diffusion tensor imaging (DTI) derived 
metrics. On the basis of NPT testing the authors find a prevalence of 50.7% for 
MHE, which is comparable to the one reported by Razek et al [8]. 
The children with CLD in comparison to the healthy children had relatively higher 
blood ammonia, but absolute levels were still in the normal range casting some 
doubts towards the ammonia hypothesis. On HMRS they had higher glutamine and 
lower choline and myoinositol in their brain. In addition they had a higher T1 signal 
intensity in the globus pallidus as well as a higher mean diffusivity in all brain regions 
on DTI, indicating cerebral oedema. Moving on to the more interesting comparisons 
between the subgroup of patients with MHE and those without MHE we see that 
between the two groups there was no difference in age, gender or aetiology of the 
liver disease. The differences in Child class, PELD and MELD score did not achieve 
statistical significance. This observation may suggest that MHE is more of a 
phenomenon related to the presence of portal hypertension rather than the degree of 
hepatic dysfunction.  
The patients with MHE had significantly higher glutamine on HMRS. As previously 
mentioned these patients overall had a higher mean diffusivity on all brain regions on 
DTI in comparison to the controls, but the patients with MHE had an even higher 
mean diffusivity in six brain regions including frontal white matter. NPT, which was 
used to diagnose the MHE, had a significant positive correlation with brain choline 
and brain myoinositol. NPT had a significant negative correlation with blood 
ammonia, IL6 and TNFα, brain glutamine and with the mean diffusivity assessed by 
DTI. This led to the authors analysing and concluding that in fact frontal white matter 
mean diffusivity was the best discriminator of MHE with a sensitivity of 73.5% and a 
specificity of 100%. 
The study by Srivastava et al [7] provides some insight and a possible explanation 
for these children’s poor school performance, by linking NPT testing with 
neuroimaging. It would have been interesting if the authors could have also 
correlated the presence of MHE with school performance. A large proportion of the 
patients studied had autoimmune liver disease, whereas a more representative 
cohort of patients with chronic liver disease would include more patients with 
cholestatic liver disease, who are affected at a younger age. Nevertheless this study 
brings objective neuroimaging into the evaluation of children with chronic liver 
disease paving the way for further studies of this kind to evaluate younger children 
with chronic liver disease for the presence of MHE. Although it is difficult to ascribe 
neurocognitive complications in children with early onset cholestatic disorders to 
  
MHE solely, the relationship intuitively appears plausible hence an early intervention 
including liver transplantation could improve long term scholastic and neurocognitive 
outcomes.  
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